Patients with diabetes who undergo cancer surgery are approximately 50% more likely to die shortly after the operation than non-diabetics.
This additional risk was present across a range of cancers and surgical treatments for the disease, according to a meta-analysis of 15 published studies that included information on short-term (30-day and hospital) postoperative mortality after initial cancer surgery.
Study sample sizes ranged from 70 to 32,621 subjects. The heightened mortality risk may be at least partially attributable to the higher infection and cardiovascular disease rates associated with diabetes. Findings appear in Diabetes Care (2010;33:931-939)
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.